期刊文献+

2型糖尿病下肢血管病变与血清胱抑素C的关系 被引量:1

The relationship between lower extremities arterial disease(LEAD)in type 2 diabetes mellitus and serum cystatin C
下载PDF
导出
摘要 目的研究2型糖尿病(T2DM)合并下肢血管病变患者的临床特点及其与血清胱抑素C(CysC)的关系。方法将103例住院T2DM患者根据有无合并下肢血管病变分为合并下肢血管病变组和无下肢血管病变组,记录患者身高、体重、腰围、臀围,进行空腹血糖(FBG)、血总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、甘油三酯(TG)、血清肌酐(Scr)、血清胱抑素C(CysC)、空腹胰岛素(FINS)测定,计算体重指数(BMI)、腰臀比(WHR)、胰岛素抵抗指数(HOMA-IR)。结果 2型糖尿病合并下肢血管病变组BMI、WHR、FINS、HOMA-IR、LDL-C、CysC较无下肢血管病变组升高(P<0.05),而FBG、TC、HDL-C、TG两组差别无统计学意义(P>0.05)。结论 2型糖尿病合并下肢血管病变组更易出现血脂异常及胰岛素抵抗。2型糖尿病合并下肢血管病变组胱抑素C水平较高。 Objective To investigate the relationship between between lower extremities arterial dis- ease(LEAD) in type 2 diabetes mellitus and serum cystatin C (CysC). Methods 103 cases of T2DM were di- vided into 2 groups with LEAD and without LEAD. Their body height, weight, waist, hip were recorded ;the lev- els of fasting blood glucose ( FBG), serum total cholesterol (TC) , serum high density lipoprotein ( HDL-C ), ser- um low density lipoprotein (LDL-C), serum triglyceride( TG), serum creatinine( Scr), serum cystatin C(CysC) and fasting serum insulin(FINS) were determined, body mass index( B MI), the waist to hip ratio (WHR)and in- sulin resistance index (HOMA-IR) were calculated. Results. Results The levels of BMI, WHR, FINS, HOMA- IR, LDL-C and CysC increased significantly in LEAD group compared with non2 LEAD group (P 〈 0.05 ), the levels of FBG, TC, HDL-C and TG had no statistical significance between two groups ( P 〉 0. 05 ). Conclusion LEAD in T2DM patients had remarkable dyslipidemia, insulin resistance and higher CysC.
出处 《中国现代药物应用》 2012年第15期18-19,共2页 Chinese Journal of Modern Drug Application
关键词 2型糖尿病 胱抑素C 下肢血管病变 Type 2 diabetes mellitus Lower extremities arterial disease Cystatin C
  • 相关文献

参考文献8

  • 1Sanae W, Takafumi O, Jun L, et al. Serum cystatin C level is a mark of end-organ damage in patients with essential hypertension. Hyper- tens Res,2003,26( 11 ) :895-899.
  • 2ArpegO.rd J, Ostergren J, de Faire U, et al. Cystatin C - a marker of peripheral atherosclerotic disease?. Atherosclerosis, 2008, 199 (2) :397-401.
  • 3Koenig W,Twardella D, Brenner H, et al. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for sec- ondary cardiovascular events: more than simply a marker of glomer- alar filtration rate. Clin Chem,2005,51 (2) :321-327.
  • 4徐志强,王骏,王鸣和.胱抑素C与冠心病相关性的研究进展[J].心血管病学进展,2008,29(1):64-67. 被引量:36
  • 5陈治奎,葛长江,胡申江.胱抑素C与心血管疾病的关系[J].生理科学进展,2003,34(3):269-271. 被引量:66
  • 60 Hare AM, Newman AB, Katz R, et al. Cystatin C and incident peripheral arterial disease events in the elderly: results from the Cardiovascular Health Study. Arch Intern Med, 2005, 165 (22) :2666.
  • 7Eriksso.n P, Deguchi H, Samnegrd A, et al. Human evidence that the cystatin C gene is implicated in focal progression of coronary ar- tery disease. Arterioscler Thmmb Vase Biol, 2004, 24:551-557.
  • 8Tsai HT, Wang PH,Tee YT, et al. Imbalanced serum concentration between cathepsin B and cystatin C in patients with pelvic inflam- matory disease. Fertil Steril, 2009, 91:549-555.

二级参考文献26

  • 1冯建芳,汪淑荣,李平,赵一鸣,孙诠,师树古,陈明哲.急性心肌梗塞病人血清巯基蛋白酶抑制肽C的变化[J].基础医学与临床,1995,15(4):45-47. 被引量:20
  • 2Lindhoh JS, Erlandsen EJ, Henneberg EW. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms. Br J Surg,2001,88 : 1472 - 1475.
  • 3Shi GP, Sukhova GK, Grubb A, et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest,1999,104 : 1191 - 1197.
  • 4Barka T,van der Noen H. Expression of the cysteine proteinase inhibitor Cystatin C gene in rat heart: use of digoxigeninlabeled probes generated by polymerase chain reaction directly for in situ and northern blot hybridizations. J Histochem Cytochem,1993,41 : 1863 - 1867.
  • 5Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA,1995,274 : 1049 - 1057.
  • 6Bostom AG, Bausserman L, Jacques PF, et al. Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine. Arterioscler Thromb Vasc Biol, 1999,19 : 2241 -2244.
  • 7Takeyabu K,Betsuyaku T,Nishimura M ,et al. Cysteine proteinases and Cystatin C in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Eur Respir J, 1998,12 : 1033 -1039.
  • 8Jonsdottir S, Palsdottir A. Molecular diagnosis of hereditary Cystatin C amyloid angiopathy. Biochem Med Metab Biol,1993,49 : 117 - 123.
  • 9Lindholt JS, Erlandsen E J, Henneberg EW. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms [ J ]. Br J Surg, 2001, 88 : 1472-1475.
  • 10Sukhova GK, Wang B, Libby P, et al. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-nun mice[ J]. Circ Res, 2005,96 : 368 -375.

共引文献94

同被引文献19

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部